Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Biopharmaceuticals

PAREXEL Reports Second Quarter Fiscal Year 2009 Financial Results

For the three months ended December 31, 2008, PAREXEL's consolidated service revenue increased 15.6% to a record $275.8 million compared with $238.7 million in the prior year period. Excluding the negative impact of foreign exchange of $25.9 million dollars in the quarter, revenue increased 26.4%. Under Generally Accepted Accounting Principles (GAAP), the Company reported operating income of $7.7 million, or 2.8% of consolidated service revenue, in the second quarter of Fiscal Year 2009, versus operating income of $20.5 million, or 8.6% of...

• View Other Issues of Law & Health Weekly
  
• View Other NewsRx Publications